Clinical Trial Update: Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in ovarian cancer patients treated with taxane/c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Aprepitant (aprepitant)
• DEXAMETHASONE (Dexamethasone)
• Ramosetron (ramosetron)

Snippet

Sponsor: Samsung Medical Center | Conditions: Chemotherapy-Induced Nausea and Vomiting, Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-10-10